by Charlie Helps FRSA | Jul 22, 2026 | Corporate Governance
Whilst 76% of corporate directors utilise artificial intelligence in their board activities, a mere 8% report having the expertise required to oversee it. You likely recognise that this expertise gap creates a vacuum where algorithmic reliance erodes institutional...
by Charlie Helps FRSA | Jul 21, 2026 | Corporate Governance
The Board remains the ultimate arbiter of clinical safety and institutional integrity. Whilst the allure of algorithmic efficiency is undeniable, many NHS leaders feel a justified trepidation regarding the opaque nature of automated decision-making. You likely...
by Charlie Helps FRSA | Jul 16, 2026 | Corporate Governance
The most dangerous assumption a Non-Executive Director can make is that presence equals protection. True NED accountability is not a static designation; it is a continuous, evidenced movement through a credible plan to fulfil a specific mandate. You likely find...
by Charlie Helps FRSA | Jul 15, 2026 | Corporate Governance
Reliance is not a passive act of trust; it is a calculated exercise of judgement rooted in the veracity of evidence. Many UK directors currently struggle with a difficult paradox: they are inundated with data yet starved of clarity. Reports frequently focus on...
by Charlie Helps FRSA | Jul 14, 2026 | Corporate Governance
Table of Contents NHS Risk Management: Beyond Compliance to Institutional Assurance The Triad of Modern NHS Risk: Clinical, Financial, and Digital Implementing a Functional Risk Management Framework The Board’s Authority in Risk Mitigation and Workflow Optimisation...
